Biochemical and Biophysical Mechanisms Governing Protein–Membrane Interactions in Metabolic Signaling

Abstract

Keywords: Protein–membrane interactions, Metabolic signaling, Membrane biophysics, Lipid nanodomains, Phosphoinositides, AMPK, PI3K/Akt, mTOR, Membrane curvature, Metabolic regulation

Introduction

Metabolic signaling networks are orchestrated through highly coordinated molecular interactions that occur within spatially organized cellular environments. Biological membranes are not merely structural barriers but dynamic regulatory platforms that control the localization, activation, and integration of signaling proteins involved in energy sensing, nutrient detection, growth regulation, and stress adaptation. The interaction between proteins and lipid bilayers represents a central organizing principle in metabolic regulation, determining signal specificity, amplitude, and duration [1,2].

Protein–membrane interactions are governed by a complex interplay between biochemical determinants, such as post-translational modifications and lipid-mediated recruitment, and biophysical determinants, including membrane charge distribution, lipid composition, curvature, fluidity, and mechanical tension [3,4]. These factors collectively establish a regulatory framework that ensures precise spatiotemporal control of metabolic pathways. Metabolic signalling pathways such as PI3K/Akt, AMPK, and mTOR are critically dependent on membrane recruitment for activation. In insulin-responsive tissues, phosphoinositide remodelling at the plasma membrane generates docking sites for pleckstrin homology domain-containing proteins, enabling activation of downstream anabolic processes [5,6]. Similarly, mTOR complex activation at lysosomal membranes requires tightly regulated lipid and protein scaffolding interactions that couple nutrient availability to growth control [7,8]. AMPK, as a central energy sensor, integrates cytosolic energy status with membrane-associated signalling complexes that influence substrate accessibility and phosphorylation dynamics [9,10].

Recent advances in high-resolution imaging, lipidomics, and molecular dynamics simulations have revealed that membrane heterogeneity and nanodomain organization play critical roles in shaping signaling outcomes [2,11]. Lipid composition affects membrane thickness, electrostatic potential, and diffusion dynamics, thereby influencing protein partitioning and conformational transitions. Moreover, oxidative stress and metabolic remodeling can alter lipid saturation and membrane fluidity, indirectly modulating signaling efficiency [12].

Understanding how biochemical regulation intersects with membrane biophysics is essential for elucidating metabolic homeostasis and its disruption in disorders such as obesity, diabetes, and cancer [6,13].

Materials and Methods

This work was conducted as a structured narrative review. Relevant contemporary literature was retrieved from PubMed, Scopus, and Web of Science databases, prioritizing recent high-impact studies alongside foundational publications essential for mechanistic context. Search terms included combinations of “protein membrane interaction,” “metabolic signaling membrane recruitment,” “lipid nanodomains metabolism,” “AMPK membrane localization,” “mTOR lysosomal signaling,” “PI3K Akt phosphoinositide,” “membrane curvature sensing,” “lipidation signaling,” and “post-translational modification membrane binding.”

Inclusion criteria consisted of peer-reviewed original research articles and high-impact reviews addressing biochemical and biophysical regulation of metabolic signaling systems. Studies focusing exclusively on non-metabolic pathways were excluded unless mechanistically relevant. Experimental methodologies referenced in the selected literature included super-resolution fluorescence microscopy, cryo-electron microscopy, atomic force microscopy, lipidomics profiling, phosphoproteomics, Förster resonance energy transfer analysis, and molecular dynamics simulations [2,11,14].

Data synthesis was performed by categorizing findings into biophysical determinants (electrostatics, curvature, lipid composition, mechanical properties) and biochemical regulatory mechanisms (post-translational modifications, lipid second messengers, redox modulation), followed by integrative interpretation.

Results and Discussion

Electrostatic interactions constitute one of the principal mechanisms governing the selective recruitment of signaling proteins to metabolically active membrane compartments. The inner leaflet of the plasma membrane is enriched in anionic phospholipids, particularly phosphatidylserine and various phosphoinositide species, which generate localized negative surface potentials [1,3]. These electrostatic fields promote the transient association of proteins containing polybasic clusters, Pleckstrin Homology (PH) domains, or other lipid-binding motifs, thereby increasing their effective concentration at the membrane interface. Such charge-dependent recruitment enhances the probability of productive protein–protein interactions and facilitates rapid signal initiation.

Phosphoinositides play a particularly critical role in defining membrane identity and signaling specificity. Among them, phosphatidylinositol (3,4,5)-trisphosphate (PIP3) functions as a key second messenger in insulin-responsive tissues. Upon activation of phosphoinositide 3-kinase (PI3K), PIP3 accumulates at the plasma membrane and serves as a docking platform for Akt and other PH domain–containing proteins [5,6]. Membrane localization induces conformational rearrangements in Akt that expose regulatory phosphorylation sites, enabling activation by upstream kinases and propagation of downstream anabolic and glucose-regulatory signals. In this context, electrostatic attraction is not merely a passive physicochemical phenomenon but a finely tuned regulatory mechanism that spatially restricts signal amplification.

Disturbances in phosphoinositide turnover or membrane charge distribution can therefore disrupt signaling fidelity. Aberrant PI3K activity, altered lipid phosphatase function, or changes in membrane lipid composition may impair PIP3 gradients, leading to defective Akt recruitment and compromised glucose uptake [6]. Such dysregulation has been strongly linked to insulin resistance, metabolic syndrome, and related cardiometabolic complications. Thus, electrostatic protein–membrane interactions operate at the intersection of membrane biophysics and metabolic biochemistry, ensuring that signaling complexes assemble with both spatial precision and functional specificity [1,3,5,6].

Disturbances in phosphoinositide turnover or membrane charge distribution can therefore disrupt signaling fidelity. Aberrant PI3K activity, altered lipid phosphatase function, or changes in membrane lipid composition may impair PIP3 gradients, leading to defective Akt recruitment and compromised glucose uptake [6]. Such dysregulation has been strongly linked to insulin resistance, metabolic syndrome, and related cardiometabolic complications. Thus, electrostatic protein–membrane interactions operate at the intersection of membrane biophysics and metabolic biochemistry, ensuring that signaling complexes assemble with both spatial precision and functional specificity [1,3,5,6].

Membrane nanodomain organization further refines signaling specificity. Cholesterol-enriched lipid nanodomains influence receptor clustering, kinase activation kinetics, and lateral diffusion constraints [2,11]. Disruption of membrane cholesterol content alters PI3K/Akt and mTOR pathway activation thresholds, demonstrating that membrane composition directly modulates metabolic signaling amplitude [7,8]. Spatial compartmentalization therefore reduces signaling cross-talk and enhances pathway precision.

Mechanical properties of membranes also contribute to metabolic regulation. Membrane curvature and tension affect protein binding affinity and conformational stability. Curvature-sensitive domains selectively associate with regions of altered topology, linking biomechanical stress to metabolic adaptation [15]. Under conditions of lipid overload or oxidative stress, membrane remodeling may alter curvature distribution and protein localization, contributing to insulin resistance and metabolic dysfunction [12,13].

Post-Translational Modifications (PTMs) provide a dynamic interface between biochemical regulation and membrane biophysics, enabling rapid and reversible modulation of protein localization and signaling activity. By altering protein charge distribution, hydrophobicity, or interaction surfaces, PTMs directly influence membrane affinity and spatial organization within signaling platforms. Phosphorylation, in particular, can introduce negatively charged phosphate groups that modify electrostatic interactions with anionic membrane lipids, either enhancing or reducing membrane association depending on the structural context. Such charge redistribution may alter conformational states, expose lipid-binding domains, or regulate interactions with adaptor proteins.

In the case of AMP-Activated Protein Kinase (AMPK), activation through phosphorylation induces structural rearrangements that influence both catalytic activity and subcellular targeting. Under conditions of energetic stress, AMPK undergoes conformational changes that enhance its interaction with upstream kinases and membrane-associated substrates, thereby coordinating metabolic adaptation with spatial redistribution of signaling complexes [9,10]. This illustrates how phosphorylation-dependent structural dynamics integrate energy sensing with membrane-proximal signaling events.

Other PTMs contribute additional layers of regulation. Ubiquitination can control the turnover, trafficking, or assembly of membrane- associated signaling complexes, thereby influencing their stability and duration of membrane residence. Acetylation may modulate protein–protein interactions and affect the accessibility of lipid-binding regions, indirectly shaping membrane recruitment kinetics [4]. Collectively, these modifications operate as finely tuned regulatory switches that couple intracellular metabolic status to the biophysical properties of membranes, ensuring temporal precision and adaptability in metabolic signaling networks [4,9,10].

Redox regulation adds an additional and highly dynamic layer of control to protein–membrane interactions in metabolic signaling. Reactive Oxygen Species (ROS), generated as by-products of mitochondrial respiration and enzymatic oxidase activity, can modify membrane lipids through peroxidation and oxidative fragmentation. Such oxidative modifications alter bilayer fluidity, lipid packing order, and membrane thickness, thereby reshaping the physical landscape in which signaling proteins operate [12]. Even moderate shifts in lipid saturation or headgroup oxidation can influence membrane viscosity and lateral heterogeneity.

Changes in membrane fluidity and packing density directly affect the lateral diffusion coefficients of both lipids and membrane- associated proteins. Reduced fluidity may constrain protein mobility and clustering dynamics, whereas increased disorder can enhance diffusion but destabilize organized signaling microdomains. Because many metabolic signaling pathways rely on transient nanocluster formation for efficient signal amplification, redox-driven membrane remodeling can either potentiate or attenuate downstream signaling depending on the cellular context [12]. In this manner, oxidative stress does not merely damage membranes but functionally reprograms signaling architecture.

Beyond direct effects on membrane fluidity and packing, Reactive Oxygen Species (ROS) can indirectly regulate protein recruitment by modifying lipid signaling intermediates that define membrane identity. Oxidative remodeling of phospholipids may alter headgroup charge distribution, acyl chain saturation, and local membrane curvature, thereby changing the affinity landscape for lipid- binding domains such as PH, C2, or PX domains. Even subtle oxidative modifications of phosphatidylserine or phosphoinositides can influence electrostatic interactions and docking efficiency of signaling proteins, ultimately reshaping the spatial organization of membrane-associated complexes [12,13].

In addition, oxidation-sensitive lipid species may affect the enzymatic activity of kinases and phosphatases responsible for phosphoinositide turnover. Perturbations in phosphoinositide gradients can compromise the recruitment of key metabolic regulators, including Akt and other growth factor–responsive kinases, thereby attenuating downstream signaling fidelity. Lipidomic and proteomic analyses increasingly demonstrate that oxidative shifts in phosphatidylserine and phosphoinositide composition are associated with altered localization and clustering behaviour of kinases and adaptor proteins involved in insulin and growth factor pathways [12,13]. These changes may influence both signal amplitude and duration by modifying membrane residency time and complex stability.

In metabolic disorders characterized by sustained oxidative stress, such as obesity and type 2 diabetes, chronic lipid peroxidation can progressively destabilize membrane microdomains required for efficient signaling assembly. Disruption of these platforms may impair insulin receptor substrate recruitment, reduce Akt activation efficiency, and promote pro-inflammatory signaling cascades. Consequently, oxidative remodeling of membrane lipids emerges not merely as a by-product of metabolic imbalance but as an active contributor to impaired glucose homeostasis and lowgrade inflammatory activation [12,13].

Thus, redox regulation functions at the intersection of membrane biophysics and metabolic biochemistry, linking mitochondrial activity and oxidative balance to spatial reorganization of signaling proteins. The cumulative evidence indicates that oxidative remodeling of membranes is not simply a consequence of metabolic dysfunction but an active determinant of signaling fidelity and metabolic adaptability [12,13].

Collectively, current evidence indicates that effective metabolic signaling depends on synchronized biochemical modification and biophysical membrane organization. Disruption at either level— whether through altered lipid composition, defective phosphorylation cascades, or mechanical membrane stress—can destabilize metabolic signaling networks and contribute to disease progression [6,13]. Future research integrating quantitative membrane biophysics with systems-level metabolic analysis will be essential for developing targeted therapeutic strategies.

Acknowledgements

None.

Conflict of Interest

None.

References

1. Cho W, Stahelin RV (2006). Membrane binding and subcellular targeting of C2 domains. Biochim Biophys Acta 1761(8): 838-849.
2. Sezgin E, Levental I, Mayor S, Eggeling C (2017) The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol 18(6): 361-374.
3. McLaughlin S, Murray D (2005) Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438(7068): 605-611.
4. Levental I, Veatch SL (2016) The continuing mystery of lipid rafts. J Mol Biol 428(24 Pt A): 4749-4764.
5. Manning BD, Toker A (2017) AKT/PKB signaling: navigating the network. Cell 169(3): 381-405.
6. Burke JE (2018) Structural basis for regulation of phosphoinositide kinases and their involvement in human disease. Mol Cell 71(5): 653-673.
7. Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168(6): 960-976.
8. Kim J, Guan KL (2019) mTOR as a central hub of nutrient signalling and cell growth. Nat Cell Biol 21(1): 63-71.
9. Hardie DG (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 32(Suppl 4): S7-S12.
10. Herzig S, Shaw RJ (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19(2): 121-135.
11. Lorent JH, Levental KR, Ganesan L, G Rivera Longsworth, E Sezgin, et al. (2020) Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape. Nat Chem Biol 16(6): 644-652.
12. Hulbert AJ (2007) Membrane fatty acids as pacemakers of animal metabolism. Lipids 42(9): 811-819.
13. Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126(1): 12-22.
14. Linder ME, Deschenes RJ (2007) Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8(1): 74-84.
15. Simunovic M, Voth GA (2015) Membrane tension controls the assembly of curvature-generating proteins. Nat Commun 6: 7219.